EUVIMED · CrossrefJournal
Hepatology Communications
ISSN 2471-254X · Ovid Technologies (Wolters Kluwer Health)
Latest articles
Circulating alpha-fetoprotein-specific T-cell responses are associated with clinical outcomes after radiofrequency ablation or immunotherapy in hepatocellular carcinoma
Predictors and prognostic impact of spontaneous portal vein thrombosis recanalization in cirrhosis: An individual patient data meta-analysis
Ascites fluid PMN counts below the SBP threshold predict 30-day mortality in a national hospitalized cirrhosis cohort
Immunosuppressive monocytes promote infection in patients with alcohol-associated hepatitis
Variability in non-invasive tests: Challenges and implications for monitoring liver disease
Muscle strength and physical activity are independent determinants of quality of life in MASLD
High adherence to trientine tetrahydrochloride among U.S. patients with Wilson disease: A nationwide specialty pharmacy analysis
Tracking Living Donor–Candidate Dyads: A Brief Report of Electronic Health Record Architecture Challenges
Longitudinal changes in a blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in cirrhosis
Serious illness care for patients with acute-on-chronic liver failure: A care model and research agenda
Alcohol impairs liver adaptation to high-cholesterol diet, leading to advanced disease development
Alcohol abstinence and liver stiffness by vibration-controlled transient elastography: A systematic review and meta-analysis
Bacteroidetes promote hepatocellular carcinoma progression and resistance to immunotherapy
Apixaban reduces hepatic decompensation in patients with cirrhosis (ApiHep): A randomized controlled trial
Patient-reported and caregiver-reported outcomes in refractory ascites secondary to cirrhosis: A systematic review and meta-analysis
Hepatocyte senescence in metabolic dysfunction–associated steatotic liver disease (MASLD)
Clinical and patient-reported predictors of days alive and out of hospital in decompensated cirrhosis
Research priorities and knowledge gaps in understanding hepatobiliary disease in cystic fibrosis
Lower circulating angiotensinogen levels across ACLD stages are associated with hepatic dysfunction and mortality
Impact of body composition on clinical outcomes in patients with hepatocellular carcinoma: A systematic review and meta-analysis
Machine learning models of noninvasive tests to predict metabolic dysfunction–associated steatohepatitis and fibrosis stage
Molecular biomarkers for diagnosis, prognosis, precision therapy, and immunotherapy in cholangiocarcinoma, cHCC-CCA, and HCC
Conserved hepatic RNA signatures across multiple cohorts reveal novel mechanistic clues for advanced fibrosis in human MASLD
Prime editing models the MTARC1 A165T variant in human liver organoids, demonstrating reduced steatosis, inflammation, and fibrosis
Sex and racial disparities in clinical outcomes and health resource use among patients with primary biliary cholangitis in the United States
Targeted community screening in areas of high socioeconomic deprivation enhances the detection of liver fibrosis
A multicenter multistate modeling on the natural history of liver decompensation: Longitudinal analysis of 1777 patients
Mild alkaline phosphatase elevation associates with increased mortality and major adverse liver outcomes in MASLD
Genetic testing and exchangeable copper can improve the accuracy of Wilson disease diagnoses
THBS1+ macrophages fuel pathogenic inflammation in alcohol-associated liver disease
EUVIMED